ABOUT ADVANCE

The goal of the ADVANCE project is to help health professionals, regulatory agencies, public health institutions, vaccine manufacturers and the general public make more informed decisions on benefits and risks of marketed vaccines.

News

01/11/2018

ADVANCE develops the Blueprint

The ADVANCE project was created in response to the 2009 A(H1N1) influenza... READ MORE

22/10/2018

ECDC presents ADVANCE solutions at VACCINATION: SCIENTIFIC AND SOCIAL PERSPECTIVES conference

ECDC has been invited to present on vaccination coverage in the EU at the... READ MORE

02/10/2018

ADVANCE Blueprint submitted to IMI

The WP7 deliverable D7.7 Blueprint of a framework to rapidly provide... READ MORE

ADVANCE TOOLBOX

ADVANCE consortium has developed the ADVANCE Toolbox which can be used by the scientific community to streamline the monitoring of the health benefits and risks of vaccines in the post licensure phase. It comprises different online open source applications that allow to transform outcome definitions into diagnosis codes, to analyse and select vaccine codes in a given vaccine coding system, assess potential impact of possible disease- and exposure misclassification, derive prevalence estimates and validity indices and visualise near real-time monitoring of the post-marketing benefits and risks of vaccines. Moreover, researchers can use ADVANCE web catalogue to conduct an assessment of the ability of databases to contribute to future vaccine benefit-risk studies.

Links